Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Trans R Soc Trop Med Hyg ; 114(9): 700-703, 2020 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-32511702

RESUMEN

Five children in Pos Lenjang, Pahang, Malaysia were PCR-positive for vivax malaria and were admitted to the hospital from 5 to 26 July 2019. One of the patients experienced three episodes of recurrence of vivax malaria. Microsatellite analysis showed that reinfection is unlikely. Drug resistance analysis indicated that Riamet (artemether-lumefantrine) is effective. Cytochrome P450 2D6 (CYP2D6) testing showed that this patient has defective CYP2D6 function. Primaquine failure to clear the Plasmodium vivax hypnozoites may be the cause of recurring infections in this patient. This report highlights the need for the development of liver-stage curative antimalarials that do not require metabolism by the CYP2D6 enzyme.


Asunto(s)
Antimaláricos , Malaria Vivax , Antimaláricos/uso terapéutico , Arteméter/uso terapéutico , Combinación Arteméter y Lumefantrina/uso terapéutico , Niño , Citocromo P-450 CYP2D6/genética , Citocromo P-450 CYP2D6/uso terapéutico , Humanos , Malaria Vivax/diagnóstico , Malaria Vivax/tratamiento farmacológico , Malasia , Plasmodium vivax/genética , Primaquina/uso terapéutico , Recurrencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...